Capital Research Global Investors
TECH icon

Capital Research Global Investors’s Bio-Techne TECH Stock Holding History

Capital Research Global Investors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185M Sell
2,621,890
-566,320
-18% -$30.6M 0.03% 246
2026
Q1 		$167M Buy
3,188,210
+1,569,328
+97% +$94.2M 0.03% 261
2025
Q4 		$95.2M Sell
1,618,882
-6,620
-0.4% -$402K 0.02% 308
2025
Q3 		$90.4M Buy
1,625,502
+619,552
+62% +$33.2M 0.02% 303
2025
Q2 		$51.8M Buy
+1,005,950
New +$50.5M 0.01% 344

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital Research Global Investors's TECH Position: Q2 2026 in Review

Capital Research Global Investors reduced its Bio-Techne (TECH) stake by 18% in Q2 2026, selling an estimated $30.6M and leaving 2,621,890 shares worth $185M. The position accounts for 0.03% of the portfolio, ranked #246.

Capital Research Global Investors first reported a position in TECH in Q2 2025 and has held it in 5 quarters since. 438 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Capital Research Global Investors held 2,621,890 shares of Bio-Techne worth $185M as of Q2 2026.
  • Capital Research Global Investors sold 566,320 Bio-Techne shares in Q2 2026, an estimated $30.6M.
  • Bio-Techne made up 0.03% of Capital Research Global Investors's portfolio in Q2 2026, its #246 holding.
  • Capital Research Global Investors first reported a position in Bio-Techne in Q2 2025 and has held it in 5 quarters since.
  • 438 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.